Patents

The following ImmunityBio, Inc. products, platforms and technology are protected by patents in the United States and elsewhere. This website page is provided to satisfy virtual patent marking provisions of various jurisdictions including the virtual patent marking provisions of the America Invents Act. In accordance with Section 287(a) of Title 35 of the United States Code, notice is given. Additional patents and patent applications may also be pending in the United States and internationally.

Aldoxorubicin and uses thereof

Application Number Grant Number
EP 13863251.8
US 16/640,336

Anktiva™ (Nogapendekin Alfa Imbakicept; also known as N-803 or Alt-803) and uses thereof

Application Number Grant Number
CN 201410242394.1 CN ZL201410242394.1
EP 11178091.2 EP 2388266
EP 15162957.3 EP 2918607
EP 15815782.6
EP 20152694.4
US 12/700,949 US 8,163,879
US 13/428,776 US 8,940,289
US 13/769,179 US 9,255,141
US 13/854,903 US 9,328,159
US 14/755,989 US 9,925,247
US 15/083,998 US 10,150,805
US 15/254,713 US 10,450,359
US 15/921,512 US 10,537,615
US 16/443,560
US 16/444,807
US 16/749,955
US 16/749,967

COVID hAd5 Vaccine Platform and uses thereof

Application Number   Grant Number
US 12/651,836   US 8,298,549

Ganitumab and uses thereof

Application Number Grant Number
US 13/891,781 US 8,895,008

hAd5 (E1-,E2b-) Platform and uses thereof

Application Number Grant Number
EP 16735415.8  
EP 16783793.9  
US 12/528,796 US 8,188,214
US 12/651,836 US 8,298,549
US 13/176,341 US 8,957,192
US 13/622,263  
US 14/422,504 US 9,605,276
US 15/433,934 US 10,563,224
US 15/564,413  
US 15/749,214 US 10,550,164
US 16/107,559  
US 16/306,097  
US 16/458,726 US 10,874,729

Nant Cancer Vaccine Platform and uses thereof

Application Number Grant Number
US 12/651,836 US 8,298,549
US 14/422,504 US 9,605,276
US 14/755,989 US 9,925,247
US 15/564,413
US 16/312,246

NK-92® Cell Platform and uses thereof

Application Number Grant Number
AU 2013200124 AU 2013200124
AU 2017210556 AU 2017210556
CN 201680019087.4  
EP 16773863.2  
EP 18763512.3  
PCT/US2019/044637  
US 10/008,955 US 10,138,462
US 10/456,237 US 8,034,332
US 11/178,258 US 7,618,817
US 15/529,848 US 10,456,420
US 15/914,665 US 10,801,013
US 16/424,201 US 10,774,310
US 16/529,159  
US 16/529,251 US 10,765,701
US 16/541,847 US 10,736,921
US 16/620,855  
US 16/934,606  
US 16/940,018  

Yeast Vaccine Platform and uses thereof

Application Number Grant Number
US 12/335,094 US 8,067,559
US 13/803,719 US 9,198,941
US 14/778,118 US 10,507,235
US 14/926,372 US 9,623,097
US 15/454,176 US 10,363,294
US 16/389,235